Author details

Full Name

Jerry M Anchin

Affiliation

ORCID

Career Start Year

1991

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
21256797	Nonlinear PD2i heart rate complexity algorithm detects autonomic neuropathy in patients with type 1 diabetes mellitus.	Clinical Neurophysiology	2011
18728829	Nonlinear analysis of the heartbeats in public patient ECGs using an automated PD2i algorithm for risk stratification of arrhythmic death.	Therapeutics and Clinical Risk Management	2008
19209249	Risk stratification for arrhythmic death in an emergency department cohort: a new method of nonlinear PD2i analysis of the ECG.	Ther Clin Risk Manag	2008
11472232	Antibody-ligand interactions: computational modeling and correlation with biophysical measurements.	Combinatorial Chemistry and High Throughput Screening	2001
10993728	The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.	J Mol Biol	2000
9417114	The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+,K+-ATPase.	Journal of Biological Chemistry	1998
9587873	Recognition of superpotent sweetener ligands by a library of monoclonal antibodies.	Journal of Molecular Recognition	1997
9194167	Analysis of high-affinity binding determinants in the receptor binding epitope of basic fibroblast growth factor.		1997
9064282	Molecular probes for sweeteners: immunorecognition of superpotent guanidinium compounds.		1996
9630894	ABGEN: a knowledge-based automated approach for antibody structure modeling.	Nat Biotechnol	1996
8519975	Structural predictions of the binding site architecture for monoclonal antibody NC6.8 using computer-aided molecular modeling, ligand binding, and spectroscopy.	Biophys J	1995
7665610	Glu-96 of basic fibroblast growth factor is essential for high affinity receptor binding. Identification by structure-based site-directed mutagenesis.	Journal of Biological Chemistry	1995
8089487	Identification of residues in monoclonal antibody NC10.8 that bind to the sweetener N-(p-cyanophenyl)-N'-(diphenylmethyl)guanidinoacetic acid by using radioligand binding, absorption and fluorescence spectroscopy, computer-aided molecular modeling, and si	Journal of Immunology	1994
7893280	Local and transmitted conformational changes on complexation of an anti-sweetener Fab.	Journal of Molecular Biology	1994
7696216	Computer-aided molecular modeling of the binding site architecture for eight monoclonal antibodies that bind a high potency guanidinium sweetener.	J Mol Graph	1994
7686135	Monoclonal antibodies to sweet taste proteins: II. Development of two different immunoassays for thaumatin and monellin.		1993
8232332	Variable region sequence and characterization of monoclonal antibodies to a N,N',N"-trisubstituted guanidine high potency sweetener.	Molecular Immunology	1993
1339485	Spectrofluorimetric study of the intermolecular complexation of monoclonal antibodies with the high potency sweetener N-(p-cyanophenyl)-N'-(diphenylmethyl) guanidineacetic acid.	Journal of Molecular Recognition	1992
1361231	Molecular mimicry of hepatitis B surface antigen by an anti-idiotype-derived synthetic peptide.	Proceedings of the National Academy of Sciences of the United States of America	1992
1931126	Binding of the neuroleptic drug haloperidol to a monoclonal antibody: refinement of the binding site molecular model using canonical structures.	J Mol Recognit	1991
1718843	Monoclonal antibodies to sweet taste proteins. I. Analysis of antigenic epitopes on thaumatin by competitive inhibition assays.		1991
2040800	Analysis of the binding site architecture of monoclonal antibodies to morphine by using competitive ligand binding and molecular modeling.	J Immunol	1991